The managing director of litigation funder Vannin Capital lost a battle to dismiss a cross claim brought against him by rival LCM in a case alleging LCM has misapplied funds in its trust.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Former ABC boss Michelle Guthrie has launched legal proceedings over her firing last month from the ABC, making an adverse action claim against the broadcaster.
Creditors of the failed Arrium Group have won access to documents handed over by third parties to the company’s administrators for possible civil proceedings against the steel producer, which collapsed owing $2.3 billion.
Optus has agreed to fork over $10 million in penalties after admitting it billed customers for premium phone services they didn’t sign up for, the consumer watchdog said Wednesday.
Failed digital ad company Unlockd has until the end of the month to set out its competition case against Google or the suit will be thrown out.
Westpac is challenging a judge’s order that gives the funder backing a class action over life insurance premiums a 25 percent cut of any recovery.
Former National Australia Bank branch manager Mathew Alwan has been permanently banned from the financial services industry for his involvement in a home loan fraud ring in greater western Sydney.